Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 62756-915

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride (NDC 62756-915). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl Cetiri Pseu

The packaging label for Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Extended-release Tablets, USP 5 mg/120 mg by Sun Pharmaceutical Industries, Inc. It is an oral film-coated tablet for antihistamine and nasal decongestant use for indoor and outdoor allergies. The label lists directions, inactive ingredients, warnings, uses, and storage information, and notes a package size of 12 tablets (two blister cards of six tablets each).*

FDA Label Image

Spl-cetirizine-pseudoephedrine-blister (Spl Cetirizine Pseudoephedrine Blister)

Labels for Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablet, USP, strength 5 mg/120 mg. Each label features the drug name, strength in a blue box, manufacturer Sun Pharmaceutical Industries, Ltd. India, and barcodes. The labels are arranged in a grid with instructions to peel.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.